Acasti Pharma Revenue, Profits - ACST Annual Income Statement

Add to My Stocks
$0.71 $0.09 (11.25%) ACST stock closing price Jun 15, 2018 (Closing)

Financial analysis of Acasti Pharma involves more than just checking the Acasti Pharma stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the ACST stock. The Acasti Pharma profit and loss statement for 2016 shows a net profit of $-7.99M. Profits for last year was $-4.84M. Apart from this an investor should also check Acasti Pharma assets and Acasti Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20162015201420132012
Acasti Pharma Revenues or Net Sales
-----
Cost Of Goods Sold (COGS)-----
Acasti Pharma Gross Profit
--0.03M---
Research & Development Expense5.51M5.66M5.8M4.11M3.01M
Selling General & Admin Expense2.48M1.67M5.26M6.42M4.29M
Income Before Depreciation Depletion Amortization-8M-7.37M-11.03M-10.33M-6.99M
Depreciation Depletion Amortization-----
Non Operating Income-0.02M2.52M9.56M-0.77M-
Interest Expense-----
Acasti Pharma Pretax Income
-8.08M-4.84M-1.47M-11.11M-6.9M
Provision for Income Taxes-0.09M----
MinorityInterest-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-7.99M-4.84M-1.47M-11.11M-6.9M
Extraordinary Items & Discontinued Operations-----
Acasti Pharma Profit/ Loss (Net Income)
-7.99M-4.84M-1.47M-11.11M-6.9M
Average Shares used to compute Diluted EPS10.8M10.71M8.28M8.29M7.28M
Average Shares used to compute Basic EPS10.8M10.71M8.28M8.29M7.28M
Income Before Nonrecurring Items-7.99M-4.85M-1.34M-11.61M-6.91M
Income from Nonrecurring Items-----
Acasti Pharma Earnings Per Share Basic Net
-0.74-0.45-0.20-1.40-0.90
Acasti Pharma Earnings Per Share Diluted Net
-0.74-0.45-0.20-1.40-0.90
EPS Diluted Before Nonrecurring Items-0.74-0.45-0.20-1.40-0.90
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Acasti Pharma stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the Acasti Pharma revenue chart, as isn't the case with Acasti Pharma indicates a sagging business. One needs to compare the YoY topline or sales growth of ACST stock with its peers like PTX stock and AGRX stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: Most businesses like Acasti Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The ACST financials along with Acasti Pharma historical stock prices provide a lot of details about the firm.

Acasti Pharma Income Statement - Key Financial Ratios

Operating Margin
0
Net Profit Margin
0